Medical device to treat anxiety cleared by the FDA

Abstract

Neurovalens, a global leader in non‐invasive neuro‐technology, has received medical device clearance from the U.S. Food & Drug Administration (FDA) to treat anxiety with its Modius Stress device, a company news release stated. Based in Belfast, Ireland, Neurovalens is a health‐tech company that specializes in combining neuroscience and technology to tackle a range of global health challenges.